Richard L. Kravitz, MD, MSPH and Jodi Halpern, MD, PhD
Patients have a responsibility to discerningly present the drug information they receive from direct-to-consumer advertising and to be active partners with their physician in making health care decisions.
Physicians are cautioned that the two obstacles to reforming post-marketing clinical trials are the FDA's reluctance to revisit past approvals and its inability to enforce pharmaceutical companies' commitment to conduct Phase IV trials.
Dr Katie Savin joins Ethics Talk to discuss their article, coauthored with Drs Laura Guidry-Grimes and Olivia S. Kates: “What Does Disability Justice Require of Antimicrobial Stewardship?”
Suggests to medical students what forms of self-disclosure are acceptable during clinical encounters and when self-disclosure might be interpreted by patients as taking attention away from them.
This commentary examines the consequences of a medical student’s dishonesty during clinical rounds when she lacked the lab results the attending physician asked her for.
Clinical case examines physicians’ duties and risks during an epidemic. Commentaries address physician’s rights vs patients’ rights. Does the duty to treat always override personal or family concerns?
In quarantine situations, the actions of autonomous individuals are restricted to protect the health of the public. Physicians enforcing quarantine should be sympathetic and clear in communicating with those whose activities are being restricted.